BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 21527913)

  • 1. LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation.
    Verweij FJ; van Eijndhoven MA; Hopmans ES; Vendrig T; Wurdinger T; Cahir-McFarland E; Kieff E; Geerts D; van der Kant R; Neefjes J; Middeldorp JM; Pegtel DM
    EMBO J; 2011 Jun; 30(11):2115-29. PubMed ID: 21527913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling.
    Hurwitz SN; Nkosi D; Conlon MM; York SB; Liu X; Tremblay DC; Meckes DG
    J Virol; 2017 Mar; 91(5):. PubMed ID: 27974566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetraspanin CD63 Bridges Autophagic and Endosomal Processes To Regulate Exosomal Secretion and Intracellular Signaling of Epstein-Barr Virus LMP1.
    Hurwitz SN; Cheerathodi MR; Nkosi D; York SB; Meckes DG
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29212935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus LMP1 Modulates the CD63 Interactome.
    Cheerathodi M; Nkosi D; Cone AS; York SB; Meckes DG
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33920772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane Domains Mediate Intra- and Extracellular Trafficking of Epstein-Barr Virus Latent Membrane Protein 1.
    Nkosi D; Howell LA; Cheerathodi MR; Hurwitz SN; Tremblay DC; Liu X; Meckes DG
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal sorting of the viral oncoprotein LMP1 is restrained by TRAF2 association at signalling endosomes.
    Verweij FJ; de Heus C; Kroeze S; Cai H; Kieff E; Piersma SR; Jimenez CR; Middeldorp JM; Pegtel DM
    J Extracell Vesicles; 2015; 4():26334. PubMed ID: 25865256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling.
    Yasui T; Luftig M; Soni V; Kieff E
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):278-83. PubMed ID: 14695890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interactome of EBV LMP1 evaluated by proximity-based BioID approach.
    Rider MA; Cheerathodi MR; Hurwitz SN; Nkosi D; Howell LA; Tremblay DC; Liu X; Zhu F; Meckes DG
    Virology; 2018 Mar; 516():55-70. PubMed ID: 29329079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceramide-dependent trafficking of Epstein-Barr virus LMP1 to small extracellular vesicles.
    York SB; Hurwitz SN; Liu X; Meckes DG
    Virology; 2023 Apr; 581():128-138. PubMed ID: 36958217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.
    Izumi KM; Cahir McFarland ED; Ting AT; Riley EA; Seed B; Kieff ED
    Mol Cell Biol; 1999 Aug; 19(8):5759-67. PubMed ID: 10409763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes.
    Aga M; Bentz GL; Raffa S; Torrisi MR; Kondo S; Wakisaka N; Yoshizaki T; Pagano JS; Shackelford J
    Oncogene; 2014 Sep; 33(37):4613-22. PubMed ID: 24662828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.
    Ersing I; Bernhardt K; Gewurz BE
    Viruses; 2013 Jun; 5(6):1587-606. PubMed ID: 23793113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
    Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.
    Devergne O; Cahir McFarland ED; Mosialos G; Izumi KM; Ware CF; Kieff E
    J Virol; 1998 Oct; 72(10):7900-8. PubMed ID: 9733827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways.
    Zhang J; Jia L; Lin W; Yip YL; Lo KW; Lau VMY; Zhu D; Tsang CM; Zhou Y; Deng W; Lung HL; Lung ML; Cheung LM; Tsao SW
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
    Thornburg NJ; Raab-Traub N
    J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
    Song YJ; Kang MS
    Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.
    Shkoda A; Town JA; Griese J; Romio M; Sarioglu H; Knöfel T; Giehler F; Kieser A
    PLoS Biol; 2012; 10(8):e1001376. PubMed ID: 22904686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.